Search clinical trials for: Pimecrolimus

Total 69 results

Actavis Inc.

Completed

Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Glenmark Pharmaceuticals Ltd. India

Completed

Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Children's Hospital of Philadelphia
Novartis Pharmaceuticals

Completed

Combination Therapy for Atopic Dermatitis

Atopic Dermatitis

United States
Par Pharmaceutical, Inc.

Completed

Safety and Bioequivalence of Pimecrolimus Cream 1% and Elidel R in Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis
Mylan Inc.
DPT Laboratories, Ltd.

Completed

Bioequivalence Study of Pimecrolimus Cream, 1% and Elidel® Cream, 1% in Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States, Dominican Republic, Honduras
Novartis

Completed

Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis

Dermatitis, Atopic

United States
GlaxoSmithKline

Withdrawn

A Comparative Study Of Iodine I 131 Tositumomab Therapeutic Regimen Versus Ibritumomab Tiuxetan Therapeutic Regimen

Lymphoma, Follicular | Lymphoma, Non-Hodgkin | Lymphoma, Small Cleaved-Cell, Follicular | Lymphoma, Large-Cell, Follicular

United States
University of Leipzig
Novartis

Withdrawn

Cutaneous Lupus Erythematosus and Elidel

Lupus Erythematosus, Cutaneous | Lupus Erythematosus, Discoid

Germany
University Hospital, Ghent
Novartis

Completed

Efficacy and Safety of Pimecrolimus for the Treatment of Vitiligo Vulgaris

Vitiligo Vulgaris

Belgium
Mylan Inc.
Medicine Meda Pharmaceutical Information Consultancy (Beijing) Co., Ltd.

Completed

Observational Study to Evaluate the Actual Use of Elidel® in Chinese Patients With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

China
Novartis

Completed

Pimecrolimus Cream 1% in Patients (18 Years of Age and Over) With Mild to Moderate Chronic Hand Dermatitis

Chronic Hand Dermatitis
Centre Hospitalier Universitaire de Nice

Terminated

Treatment of Oral Erosive Lichen Planus With Pimecrolimus Cream

Oral Erosive Lichen Planus
St Joseph University, Beirut, Lebanon

Unknown

Efficacy of Topical Pimecrolimus in the Treatment of Pityriasis Alba

Pityriasis Alba

Lebanon
Novartis

Completed

Reconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis

Atopic Dermatitis

Germany
Emer, Jason, M.D.
Ferndale Laboratories

Completed

Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.

Atopic Dermatitis

United States
Novartis

Completed

Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis

Atopic Dermatitis

Philippines
Children's Hospital of Philadelphia
Novartis Pharmaceuticals

Completed

Safety Study of Elidel (Pimecrolimus) 1% Cream to Treat Netherton Syndrome

Netherton Syndrome

United States
LEO Pharma

Completed

A Multi-Centre Clinical Trial to Evaluate a Left-Right Design in Adults With Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

Germany
University of Utah
Novartis

Completed

Pimecrolimus Cream for Oral Lichen Planus

Oral Lichen Planus

United States
Conor Medsystems

Terminated

Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

Coronary Disease

Brazil
Novartis

Completed

Extension Study to Assess Safety and Efficacy of Pimecrolimus in Adult Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
Famy Life Sciences, a Viatris Company

Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Pimecrolimus 0.3% Ophthalmic Ointment

Blepharitis

United States
Novartis

Completed

A Quality of Life and Safety Study With Pimecrolimus Cream, 1% in Children (Age 2-12 Years) With Atopic Dermatitis

Atopic Eczema

South Africa
Sanofi

Recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor (AQUA)

Dermatitis Atopic

United States, Chile, Canada, United Kingdom
Astellas Pharma Inc

Completed

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

Dermatitis, Atopic

United States
Cordis Corporation
Conor Medsystems

Completed

A Randomized, Multi-Center Study of the Pimecrolimus-Eluting and Pimecrolimus/Paclitaxel-Eluting Coronary Stent Systems (GENESIS)

Coronary Disease

United Kingdom
Astellas Pharma Inc

Completed

A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

Dermatitis, Atopic

United States, Canada
Astellas Pharma Inc

Completed

Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

Dermatitis, Atopic

United States
Technische Universität Dresden

Completed

Comparison of Atrophogenic Effect of Hydrocortison 1% Cream and Pimecrolimus 1% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHz Ultrasound of Uninvolved Skin in Patients With Atopic Dermatitis (OCT-AD)

Atopic Dermatitis

Germany
Mashhad University of Medical Sciences

Unknown

A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus

Oral Lichen Planus

Iran, Islamic Republic of
Frankel, Amylynne, M.D.
Onset Therapeutics, Inc

Completed

Bilateral Comparison Study of Elidel 1% and Hylatopic Plus Emollient Foam for the Treatment of Subjects With Atopic Dermatitis

Eczema | Atopic Dermatitis

United States
Ceragenix Pharmaceuticals

Completed

Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis

Atopic Dermatitis

United States
Center for Vulvovaginal Disorders
Novartis

Completed

Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus

Lichen Sclerosus

United States
University Hospital, Ghent

Completed

Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis) (Koebner)

Vitiligo

Belgium
Pfizer

Terminated

A Study of Crisaborole Ointment 2%; Crisaborole Vehicle; TCS and TCI in Subjects Aged ≥ 2 Years, With Mild-moderate AD

Atopic Dermatitis

United States, Poland, Germany, United Kingdom, Italy, Sweden, Switzerland
Children's Hospital of Michigan
Novartis Pharmaceuticals

Terminated

Study of Pimecrolimus Treatment for Atopic Dermatitis of African American Children

Atopic Dermatitis
Dermatology Specialists Research
Novartis

Completed

A 4 Week Study of Elidel (Pimecrolimus) for the Treatment of Seborrheic Dermatitis

Seborrheic Dermatitis

United States
Shahid Beheshti University of Medical Sciences

Completed

Comparing the Therapeutic Efficacy of Pimecrolimus Cream With Betamethasone Cream for Discoid Lupus Erythematosus

Discoid Lupus Erythematosus

Iran, Islamic Republic of
Technische Universität Dresden

Completed

Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound (OCT)

Healthy

Germany
National Medical Research Center for Children's...

Completed

Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life

Atopic Dermatitis

Russian Federation
Ain Shams University

Completed

Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus

Oral Lichen Planus
Novartis Pharmaceuticals

Completed

Assessment of Pruritus Improvement With Pimecrolimus Treatment on the Areas Affected by Mild-to-moderate AD, in Patients 2- to 11- Year-old

Atopic Dermatitis

Spain
Novartis

Completed

Extension Study of Pimecrolimus Cream in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Japan
LEO Pharma

Completed

A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD)

Atopic Dermatitis

Canada, Israel
Bausch Health Americas, Inc.
Clinical Research Computing Unit (University of Pennsylvania)

Recruiting

10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus (PEER)

Atopic Dermatitis

United States
Novartis

Completed

Open-label Study to Investigate Systemic Exposure in Adult and Pediatric Atopic Dermatitis Patients Treated 8.5 Days With Pimecrolimus Cream 1% Under Occlusion

Atopic Dermatitis

Germany
Novartis Pharmaceuticals

Completed

Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting

Atopic Dermatitis

Venezuela, Mexico
Bayer

Completed

A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis

Mild to Moderate Atopic Dermatitis

Germany
Novartis

Completed

Steroid-Sparing Effect With Pimecrolimus in Pediatric Patients With Atopic Dermatitis

Atopic Dermatitis

Germany
Novartis

Completed

Quality of Life Study in Adults With Facial Eczema

Atopic Dermatitis

United Kingdom

3

Subscribe